Attend CSSi LifeSciences J.P. Morgan Healthcare Partnering Forum


These Four Leading CROs in Maryland are Driving Success in Life Sciences

Published June 8, 2023

Biotoxtech and CSSi LifeSciences Strengthen Business Cooperation for New Drug Development

Published April 19, 2023

SiSaf’s Innovative RNA Therapeutic for Rare Genetic Skeletal Disorders Begins the U.S. Regulatory Process for Orphan Drug Designation

Published October 12, 2022

CSSi LifeSciences Partners with DevLab Bio to Speed Commercialization of Therapeutic and Medical Device Technologies

Published June 21, 2022

BioCurity Pharmaceuticals Inc. ('BioCurity' or ‘Company’) Announces Presentation at ACRO Summit 2022 on Sensitizing Head and Neck Cancer to Radiation Using the Company’s Cerium Oxide Nanoparticles | Business Wire

Published March 10, 2021

Tonic Bioventures and CSSi LifeSciences Enter Partnership to Form A New Life Sciences Fund

Published January 6, 2021

Ernesto P. Chanona, Ph.D. Joins CSSi LifeSciences As Director of Business Development

Published January 5, 2021